Trends in disparate treatment of African American men with localized prostate cancer across national comprehensive cancer network risk groups

Urology

Volumn 84, Issue 2, 2014, Pages 386-392

  Mahal, Brandon A ^a   Aizer, Ayal A ^b   Ziehr, David R ^a   Hyatt, Andrew S ^a   Sammon, Jesse D ^c   Schmid, Marianne ^a   Choueiri, Toni K ^a   Hu, Jim C ^d   Sweeney, Christopher J ^a   Beard, Clair J ^a   D'Amico, Anthony V ^a   Martin, Neil E ^a   Kim, Simon P ^e   Trinh, Quoc Dien ^a   Nguyen, Paul L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; DEMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HEALTH CARE DISPARITY; HIGH RISK POPULATION; HUMAN; INTERMEDIATE RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE;

AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84905108938     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.05.009     Document Type: Article

References (30)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Prostate cancer 2014. Available at: http://www.nccn.org. Accessed 30 December 2013.
3. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
4. A.W. Partin, M.W. Kattan, and E.N. Subong et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
5. A. Widmark, O. Klepp, and A. Solberg et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Lancet 373 2009 301 308
6. P. Warde, M. Mason, and K. Ding et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial Lancet 378 2011 2104 2111
7. N. Mottet, M. Peneau, and J.J. Mazeron et al. Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial Eur Urol 62 2012 213 219
8. A.V. D'Amico, M.H. Chen, and A.A. Renshaw et al. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289 295
9. C.U. Jones, D. Hunt, and D.G. McGowan et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 2011 107 118
10. A. Bill-Axelson, L. Holmberg, and M. Ruutu et al. Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
11. S.B. Zeliadt, A.L. Potosky, and R. Etzioni et al. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999 Urology 64 2004 1171 1176
12. W. Underwood, S. De Monner, and P. Ubel et al. Racial/ethnic disparities in the treatment of localized/regional prostate cancer J Urol 171 2004 1504 1507
13. D.A. Barocas, D.T. Gray, and J.H. Fowke et al. Racial variation in the quality of surgical care for prostate cancer J Urol 188 2012 1279 1285
14. C.R. Ritch, B.F. Morrison, and G. Hruby et al. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison BJU Int 111 2013 186 190
15. G.B. Taksler, N.L. Keating, and D.M. Cutler Explaining racial differences in prostate cancer mortality Cancer 118 2012 4280 4289
16. Y.S. Ha, A. Salmasi, and M. Karellas et al. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance Urology 81 2013 831 835
17. S.D. Ellis, B. Blackard, and W.R. Carpenter et al. Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina Cancer 119 2013 2282 2290
18. C.J. Presley, A.C. Raldow, and L.D. Cramer et al. A new approach to understanding racial disparities in prostate cancer treatment J Geriatr Oncol 4 2013 1 8
19. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program: research data (1973-2010), National Cancer Institute, DCCPS, surveillance research program, surveillance systems branch, based on November 2012 SEER data submission, posted to the SEER website, April 2013. Available at: http://seer.cancer.gov/data/. Accessed December 27, 2013.
20. United States Census Bureau. Census 2000 Gateway [online database]. Available at: http://www.census.gov/main/www/cen2000html. Accessed 27 December 2013.
21. United States Department of Agriculture Rural-Urban Continuum Codes [online database]. Available at: http://www.ers.usda.gov/data-products/rural- urban-continuum-codes.aspx. Accessed 27 December 2013.
22. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk JSTOR 94 1999 496 509
23. V. Coviello, and M. Boggess Cumulative incidence estimation in the presence of competing risks SJ 4 2004 103 112
24. E. Ward, M. Halpern, and N. Schrag et al. Association of insurance with cancer care utilization and outcomes CA Cancer J Clin 58 2008 9 31
25. C.H. Halbert, B. Weathers, and E. Delmoor et al. Racial differences in medical mistrust among men diagnosed with prostate cancer Cancer 115 2009 2553 2561
26. J.J. Ryoo, D.L. Ordin, and A.L. Antonio et al. Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol 31 2013 2716 2723
27. Hamilton AS, Fleming ST, Wang D, et al. Clinical and demographic factors associated with receipt of non guidelineconcordant initial therapy for nonmetastatic prostate cancer [e-pub ahead of print]. Am J Clin Oncol. doi: 10.1097/COC.0000000000000017, accessed February 10, 2014.
28. D.A. Barocas, R. Grubb III, and A. Black et al. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial Cancer 119 2013 2223 2229
29. D. Sundi, A.E. Ross, and E.B. Humphreys et al. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 31 2013 2991 2997
30. W.A. Stokes, L.H. Hendrix, and T.J. Royce et al. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study Cancer 119 2013 2486 2493